Investors

Our Cancer Impact Club is a community of business builders whose philanthropy, expertise and networks will multiply our impact on early-stage cancer ventures. It comprises entrepreneurs and leaders from private equity, venture capital, and associated companies and will bring together up to 50 members to raise £5m to help double our Seed Fund’s impact.

These invite-only events showcase innovative companies from across our start-up portfolio that are reaching major milestones towards patient impact, bringing together like-minded oncology investors and innovators for networking and insights.

Get in touch with our team to learn when our next Investor Networking Breakfast is taking place. 

We've built an incredible assembly line for start-up companies to bring early-stage technologies out of the research lab and translate them into patient benefit.

To date, we've played a role in the creation of 79 start-ups, with our portfolio of existing companies raising in excess of £3bn in total capital.

We're keen to connect with seed and series A-focused funds to create and grow new companies offering unique early-stage investment opportunities.

Our Seed Fund investments are catalytic, with Cancer Research Horizons considered a validating investor by like-minded early-stage investors.  An important impact measure for the fund is to leverage third-party capital alongside our own investments.  

Our world-class expert network, drawn from our extensive research community and partners, comprises leading business, scientific, clinical, investment, and industry experts across the oncology sector.

Their unrivalled experience and expertise help empower our researchers and founding teams, and maximise the success of our venture, licensing, and partnership opportunities.